Propanc Biopharma signs MOU with Avance Clinical for Phase 1 trial

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/22/2026

1. USO
2. META
3. NVDA
4. SPY
5. DCOY
6. MSFT
7. PRGS
8. VKTX
9. GS
10. UNG

Go back to Propanc Biopharma signs MOU with Avance Clinical for Phase 1 trial
(NASDAQ: PPCB) Delayed: 0.65 +0.02 (3.17%)
Previous Close $0.63    52 Week High $ 
Open $0.65    52 Week Low $ 
Day High $0.68    P/E N/A 
Day Low $0.64    EPS $ 
Volume 420,918